MacroGenics Inc (MGNX) — Cash Flow-to-Debt Ratio
MacroGenics Inc (MGNX) has a Cash Flow-to-Debt Ratio of 0.21x as of December 2025, meaning its operating cash flow of $43.02 Million could theoretically repay 0% of its total liabilities ($201.25 Million) in one year. See cash generation quality of MacroGenics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MacroGenics Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for MacroGenics Inc across 15 annual periods. Also explore how fast is MacroGenics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for MacroGenics Inc (2011–2025)
Year-by-year debt coverage analysis for MacroGenics Inc. For market capitalisation and broader financial context, see MacroGenics Inc (MGNX) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.40x | $-81.04 Million | $201.25 Million | ▲ +14.3% |
| 2024 | -0.47x | $-68.37 Million | $145.60 Million | ▲ +12.4% |
| 2023 | -0.54x | $-78.20 Million | $145.81 Million | ▲ +9.0% |
| 2022 | -0.59x | $-86.96 Million | $147.50 Million | ▲ +60.8% |
| 2021 | -1.50x | $-143.83 Million | $95.63 Million | ▼ -11.4% |
| 2020 | -1.35x | $-111.90 Million | $82.86 Million | ▲ +17.7% |
| 2019 | -1.64x | $-134.27 Million | $81.87 Million | ▲ +4.5% |
| 2018 | -1.72x | $-153.23 Million | $89.25 Million | ▼ -989.7% |
| 2017 | 0.19x | $14.40 Million | $74.64 Million | ▲ +118.8% |
| 2016 | -1.03x | $-43.68 Million | $42.51 Million | ▼ -245.5% |
| 2015 | -0.30x | $-13.66 Million | $45.93 Million | ▲ +52.2% |
| 2014 | -0.62x | $-32.76 Million | $52.60 Million | ▼ -106.0% |
| 2013 | -0.30x | $-14.17 Million | $46.87 Million | ▼ -184.8% |
| 2012 | -0.11x | $-6.58 Million | $61.98 Million | ▼ -226.0% |
| 2011 | 0.08x | $6.76 Million | $80.16 Million | — |